LongevityEstablished

Angiotensin 1-7

Angiotensin-(1-7)

AI explanation

Angiotensin 1-7: A Protective Balance in Your Body

Angiotensin 1-7 is a small protein fragment that acts like your body's natural brake pedal on inflammation and blood vessel tightness. People study it because it appears to protect your heart, kidneys, and metabolic health—essentially doing the opposite of what another similar molecule called angiotensin II does, which tightens vessels and promotes inflammation.

Here's how it works: Think of your body as having two competing systems in charge of blood pressure and inflammation. Angiotensin II is the "go" signal—it makes blood vessels constrict and triggers inflammation. Angiotensin 1-7 is the "ease off" signal. Your body produces angiotensin 1-7 using an enzyme called ACE2, which acts like a converter transforming one molecule into another. Once created, angiotensin 1-7 docks onto special receivers in your cells called Mas receptors, which then release a relaxing chemical called nitric oxide. This widening of blood vessels, reduction in inflammation, and better insulin sensitivity all flow from that single activation. Your kidneys and heart seem especially responsive to this protection. The balance between these two competing systems largely determines your cardiovascular health—so maintaining enough angiotensin 1-7 is increasingly seen as important for preventing heart disease and metabolic problems.

Dosage Information

Typical Dose

Research compound — no established human therapeutic dosing

Frequency

N/A for therapeutic use

Anytime

Administration

Intravenous or subcutaneous in research

Half-Life

~10 seconds

Notes

Several formulations are in clinical trials including inhaled versions for COVID-19 complications. Not currently available as a commercial therapeutic outside of trials.

Why this matters

Extremely rapid degradation; research use only with specialized formulations.

Dose Calculator

Calculate your draw amount for an insulin syringe (U-100)

Concentration: 2,500 mcg/mL

Sign in to save your reconstitution settings for this peptide

Draw to the

10

unit mark

020406080100

Draw 10 units for your 250mcg dose of Angiotensin 1-7

This calculator is for educational purposes. Always verify your calculations and consult a healthcare professional.

Where does Angiotensin 1-7 sit?

See how this peptide compares across all 150 peptides in our database.

Evidence Score

0.67

Clinical trials
1.0035%
Literature
0.5730%
Community
0.0020%
Completeness
1.0015%
1 RCTs5 reviews

Compound Data

Angiotensin 1-7 structure

Molecular Formula

C41H62N12O11

Molecular Weight

899.00 g/mol

IUPAC Name

(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-carboxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carboxylic acid

PubChem CID

123805

Potential Side Effects

Research compound — limited safety data outside clinical trialsHypotension with vasodilatory effects (dose-dependent)Generally well tolerated in completed trials
Pep Talk

Angiotensin 1-7 discussions

Quick Facts

Administration
Intravenous or subcutaneous in research
Typical Dose
Research compound — no established human therapeutic dosing
Frequency
N/A for therapeutic use
References
0 curated + 49 from PubMed
Clinical Trials
50 registered
Evidence Score
0.7 / 100

Frequently Asked Questions about Angiotensin 1-7

What is Angiotensin 1-7?

Angiotensin 1-7 is a seven-amino-acid peptide component of the renin-angiotensin system (RAS) that acts as a counter-regulatory axis to the classical angiotensin II pathway. While angiotensin II promotes vasoconstriction inflammation and fibrosis angiotensin 1-7 has opposing vasodilatory anti-inflammatory and anti-fibrotic effects. It has been studied extensively for cardiovascular protection kidney disease COVID-19 complications and metabolic syndrome. Interest in angiotensin 1-7 increased dramatically during the COVID-19 pandemic when ACE2 — the enzyme that produces angiotensin 1-7 — was identified as the SARS-CoV-2 receptor.

How does Angiotensin 1-7 work?

Angiotensin 1-7 is produced from angiotensin II by ACE2 (angiotensin-converting enzyme 2) and acts through the Mas receptor — a G-protein-coupled receptor that mediates its protective cardiovascular and anti-inflammatory effects. Mas receptor activation opposes angiotensin II signaling by promoting nitric oxide release causing vasodilation reducing oxidative stress and inhibiting NF-κB-mediated inflammation. In the kidney angiotensin 1-7 reduces fibrosis and protects against hypertensive nephropathy. In the heart it improves cardiac function after injury and reduces pathological remodeling. In metabolic disease it improves insulin sensitivity and reduces adipose inflammation. The ACE/ACE2 balance — producing angiotensin II vs angiotensin 1-7 respectively — is a major determinant of cardiovascular risk and has become a key target in hypertension and cardiometabolic therapeutics.

What is the recommended dosage for Angiotensin 1-7?

The typical dose is Research compound — no established human therapeutic dosing. N/A for therapeutic use. Administration: Intravenous or subcutaneous in research. Several formulations are in clinical trials including inhaled versions for COVID-19 complications. Not currently available as a commercial therapeutic outside of trials.

What are the side effects of Angiotensin 1-7?

Research compound — limited safety data outside clinical trials. Hypotension with vasodilatory effects (dose-dependent). Generally well tolerated in completed trials

Questions reflect common community inquiries. This is not medical advice.